摘要
背景:阿尔茨海默病(AD)诊断的最新研究主要集中在神经影像学模式上,但这些方法昂贵、侵入性强,并非所有患者都能使用。b型眼显像边缘视网膜的多标记物,如DRUSEN,可为AD的诊断提供一种新的方法。 目的:比较对照组和AD组的黄斑和外周膜疣负荷。 方法:取供者经病理诊断为AD的死后眼组织。正常供体的视网膜被处理并分类为较年轻(<55岁)和年龄(>55岁)。RS)组。固定和解剖后,在黄斑部和周边(颞、上、下)视网膜区域中取3-6mm的RPE /脉络膜穿孔。油红O阳性玻璃疣计数分为两大类:小(<63μm)和中间(63-125μm)。 结果:老年组黄斑部和周围硬膜部的总数目明显高于正常组(P<0.05)。中间硬鼓风较常见。AD眼颞区ND与老年性正常眼相比,即使控制年龄,也有显着性差异(P<0.05)。在AD供者的大脑和眼睛组织中,两者之间存在着显著的相关性。n脑淀粉样血管病变(CAA)的严重程度和颞中硬组织的数目(r=0.78,p<0.05)。结论:眼内颞叶DRUSEN显像对诊断和诊断有一定的价值。AD环进展我们对AD眼CAA严重程度和颞中位DRUSEN的研究结果是新的。为了进一步了解CAA和drusen形式之间的相互作用,还需要进一步的研究。增强辐射,文明阶段.
关键词: 阿尔茨海默病,周围性痴呆,生物标志物,颞叶视网膜,眼睛,大脑。
Current Alzheimer Research
Title:Drusen in the Peripheral Retina of the Alzheimer’s Eye
Volume: 15 Issue: 8
关键词: 阿尔茨海默病,周围性痴呆,生物标志物,颞叶视网膜,眼睛,大脑。
摘要: Background: Recent work on Alzheimer's disease (AD) diagnosis focuses on neuroimaging modalities; however, these methods are expensive, invasive, and not available to all patients. Ocular imaging of biomarkers, such as drusen in the peripheral retina, could provide an alternative method to diagnose AD.
Objective: This study compares macular and peripheral drusen load in control and AD eyes.
Methods: Postmortem eye tissues were obtained from donors with a neuropathological diagnosis of AD. Retina from normal donors were processed and categorized into younger (<55 years) and older (>55 years) groups. After fixation and dissection, 3-6 mm punches of RPE/choroid were taken in macular and peripheral (temporal, superior, and inferior) retinal regions. Oil red O positive drusen were counted and grouped into two size categories: small (<63 μm) and intermediate (63-125 μm).
Results: There was a significant increase in the total number of macular and peripheral hard drusen in older, compared to younger, normal eyes (p<0.05). Intermediate hard drusen were more commonly found in the temporal region of AD eyes compared to older normal eyes, even after controlling for age (p<0.05). Among the brain and eye tissues from AD donors, there was a significant relationship between cerebral amyloid angiopathy (CAA) severity and number of temporal intermediate hard drusen (r=0.78, p<0.05).
Conclusion: Imaging temporal drusen in the eye may have benefit for diagnosing and monitoring progression of AD. Our results on CAA severity and temporal intermediate drusen in the AD eye are novel. Future studies are needed to further understand the interactions among CAA and drusen formation.
Export Options
About this article
Cite this article as:
Drusen in the Peripheral Retina of the Alzheimer’s Eye, Current Alzheimer Research 2018; 15 (8) . https://dx.doi.org/10.2174/1567205015666180123122637
DOI https://dx.doi.org/10.2174/1567205015666180123122637 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
7-aa Peptide Mimic from HVR1 of HCV Protects Hepatic Injury in Rats by Reduced Expression of Key Pro-Inflammatory Factors
Inflammation & Allergy - Drug Targets (Discontinued) Altering the Sphingosine-1-Phosphate/Ceramide Balance: A Promising Approach for Tumor Therapy
Current Pharmaceutical Design Skp2 Inhibitors: Novel Anticancer Strategies
Current Medicinal Chemistry Neurotrophic Factor Treatment After Spinal Root Avulsion Injury
Central Nervous System Agents in Medicinal Chemistry AKT Signaling in Regulating Angiogenesis
Current Cancer Drug Targets Redox Control of Cardiovascular Homeostasis by Angiotensin II
Current Pharmaceutical Design Regeneration of Pancreatic β-Cells in vivo as a Potential Therapeutic Approach for Diabetes Mellitus
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Genetic Variations in Telomere Maintenance, with Implications on Tissue Renewal Capacity and Chronic Disease Pathologies
Current Pharmacogenomics and Personalized Medicine Current Targets for Anticancer Drug Discovery
Current Drug Targets Cancer: A Problem of Developmental Biology; Scientific Evidence for Reprogramming and Differentiation Therapy
Current Drug Targets Tyrosine Kinase Receptor Transactivation Associated to G Protein-Coupled Receptors
Current Drug Targets Importance of Wnt Signaling in the Tumor Stroma Microenvironment
Current Cancer Drug Targets Hsp90: A Novel Target for Cancer Therapy
Current Topics in Medicinal Chemistry Therapeutic Polycomb Targeting in Human Cancer
Recent Patents on Regenerative Medicine Epigenetic Therapies of Cancer
Current Cancer Therapy Reviews Nanosponges Encapsulated Phytochemicals for Targeting Cancer: A Review
Current Drug Targets Cell Penetrating Peptides as a Therapeutic Strategy in Chronic Lymphocytic Leukemia
Protein & Peptide Letters Anticarcinogenic Actions of Tributyrin, A Butyric Acid Prodrug
Current Drug Targets Short-Chain Fatty Acid Inhibitors of Histone Deacetylases: Promising Anticancer Therapeutics?
Current Cancer Drug Targets Stress-Activated MAP Kinase Cascades in Cellular Senescence
Current Medicinal Chemistry